| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rezolute, Inc. | Chief Medical Officer | Common Shares | 54.4K | $215K | $3.96 | Jun 14, 2024 | Direct |
| Rezolute, Inc. | Chief Medical Officer | Common Shares | 13K | $50.8K | $3.91 | Jun 14, 2024 | Held in IRA |
| Rezolute, Inc. | Chief Medical Officer | Common Shares | 1.38K | $5.46K | $3.97 | Jun 14, 2024 | Held by minor child |
| Rezolute, Inc. | Chief Medical Officer | Employee Stock Option (Right to Buy) | 130K | Jan 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RZLT | Rezolute, Inc. | Jun 14, 2024 | 4 | $29.7K | 4 | Jun 14, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | May 23, 2024 | 2 | $20.1K | 4 | May 28, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Mar 28, 2024 | 1 | $1.28K | 4 | Mar 29, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Mar 14, 2024 | 1 | $18.8K | 4 | Mar 18, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Mar 7, 2024 | 1 | $925 | 4/A | Mar 18, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Mar 7, 2024 | 1 | $925 | 4 | Mar 11, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Feb 23, 2024 | 2 | $13.5K | 4 | Feb 27, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Feb 16, 2024 | 1 | $9.14K | 4 | Feb 21, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Jan 23, 2024 | 1 | $0 | 4 | Jan 25, 2024 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Jul 3, 2023 | 1 | $9.5K | 4 | Jul 6, 2023 | Chief Medical Officer |
| RZLT | Rezolute, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Sr VP, Clinic Development |
| RZLT | Rezolute, Inc. | May 17, 2022 | 3 | $4.86K | 4 | May 19, 2022 | Sr VP, Clinic Development |
| RZLT | Rezolute, Inc. | May 4, 2022 | 1 | $80K | 4 | May 6, 2022 | Sr VP, Clinic Development |
| RZLT | Rezolute, Inc. | Jun 14, 2021 | 3 | $0 | 4 | Jul 14, 2021 | Sr VP, Clinic Development |